Myriad Genetics | Les Charges D'Exploitation



Operating Expenses Changement Date
Agilent USD 1.31B 12M 2025-01
Becton, Dickinson and Co. USD 4.72B 74M 2024-12
Bio-Rad Laboratories USD 609.1M 23.84M 2024-12
Bruker USD 915.5M 119.2M 2024-12
Danaher USD 5.11B 273M 2024-12
Exact Sciences USD 1.59B 841.72M 2024-12
Hologic USD 792M 34M 2024-12
Illumina USD 929M 590M 2024-12
J&J USD 18.63B 500M 2024-12
Mettler Toledo International USD 730.58M 884.93M 2024-12
Myriad Genetics USD 249.6M 16.3M 2024-12
Quest Diagnostics USD 2.26B 125M 2024-12
Quidel USD 808.2M 96.1M 2024-12
Repligen USD 162.7M 10.11M 2024-09
Revvity USD 610.62M 24.72M 2024-12
Standard Biotools USD 79.54M 2.85M 2024-12
Thermo Fisher Scientific USD 9.38B 619M 2024-12
Veracyte USD 114.46M 10.61M 2024-12
Waters USD 580.45M 51.28M 2024-12



Myriad Genetics Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.